Gabriela Colpo

Dr. Gabriela Colpo


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in Brain Research
Verified
Journal Article
Closed access
FLFernanda Martins Lopes
Fernanda Martins Lopes
RSRafael Schröder
Rafael Schröder
MJMário Luiz Conte da Frota Júnior
Mário Luiz Conte da Frota Júnior
Alfeu Zanotto-FilhoAlfeu Zanotto-Filho
Alfeu Zanotto-Filho
CMCarolina Beatriz Müller
Carolina Beatriz Müller
FKFabio Klamt
Fabio Klamt

1 August 2011 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
BFBrisa Simões Fernandes
Brisa Simões Fernandes
CGClarissa Severino Gama
Clarissa Severino Gama
KCKeila Maria Ceresér
Keila Maria Ceresér
LYLakshmi N. Yatham
Lakshmi N. Yatham
Gabriel FriesGabriel Fries
Gabriel Fries
FKFlavio Kapczinski
Flavio Kapczinski

9 November 2017 in Frontiers in Psychiatry
Verified
Journal Article
Open access
DADeepa Anand
Deepa Anand
GCGabriela Colpo
Gabriela Colpo
GZGregory Zeni
Gregory Zeni
CZCristian P. Zeni
Cristian P. Zeni
Antonio TeixeiraAntonio Teixeira
Antonio Teixeira
Background: Attention deficit/hyperactivity disorder (ADHD) is a complex condition that interferes with development and/or functioning. Our objective is to investigate the potential association between ADHD and inflammation. Methods: We conducted a systematic review of human studies measuring inflammatory markers in ADHD. The studies were identified by searching PUBMED, MEDLINE, EMBASE, PSYCHINFO, COCHRANE and SCOPUS databases for peer-reviewed journals published until September 2016. We included cytokine gene expression and protein measured. Fourteen papers met the inclusion criteria. Results: Seven studies evaluated the association of cytokine gene polymorphisms in ADHD, and six studies measured cytokines levels in blood. One study analyzed the presence of cytokines in CSF in patients with ADHD. Altogether, these studies indicate a possible role of inflammation in ADHD pathogenesis, despite the significant heterogeneity and contradictory results. Conclusion: Evidence points to the association of ADHD with inflammatory processes, but more studies are warranted.

1 September 2017 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
PSPavani Sayana
Pavani Sayana
GCGabriela Colpo
Gabriela Colpo
LSLutiana R. Simões
Lutiana R. Simões
VGVijayasree Giridharan
Vijayasree Giridharan
Antonio TeixeiraAntonio Teixeira
Antonio Teixeira
BTBarichello Tatiana
Barichello Tatiana

15 March 2014 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Closed access
PDF file
IGIria Grande
Iria Grande
PMP. V. Magalhães
P. V. Magalhães
ICI. Chendo
I. Chendo
LSL. Stertz
L. Stertz
BPB. Panizutti
B. Panizutti
Eduard VietaEduard Vieta
Eduard Vieta

1 July 2011 in Expert Review of Neurotherapeutics
Verified
Journal Article
Closed access
Vicent Balanzá-MartínezVicent Balanzá-Martínez
Vicent Balanzá-Martínez
Gabriel FriesGabriel Fries
Gabriel Fries
GCGabriela Colpo
Gabriela Colpo
PSPatricia P Silveira
Patricia P Silveira
APAndré K Portella
André K Portella
FKFlávio Kapczinski
Flávio Kapczinski
Bipolar disorder (BD) is a severe, chronic affective disorder, associated with significant disability, morbidity and premature mortality. Omega-3 polyunsaturated fatty acids (PUFAs) play several important roles in brain development and functioning. Evidence from animal models of dietary omega-3 (n-3) PUFA deficiency suggest that these fatty acids are relevant to promote brain development and to regulate behavioral and neurochemical aspects related to mood disorders, such as stress responses, depression and aggression, as well as dopaminergic content and function. Preclinical and clinical evidence suggests roles for PUFAs in BD. n-3 PUFAs seem to be an effective adjunctive treatment for unipolar and bipolar depression, but further large-scale, well-controlled trials are needed to examine its clinical utility in BD. The use of n-3 as a mood stabilizer among BD patients is discussed here. This article summarizes the molecular pathways related to the role of n-3 as a neuroprotective and neurogenic agent, with a specific focus on BDNF. It is proposed that the n-3-BDNF association is involved in the pathophysiology of BD and represents a promising target for developing a novel class of rationally devised therapies.